Last reviewed · How we verify

PCNA Inhibitor AOH1996

City of Hope Medical Center · Phase 1 active Small molecule

PCNA Inhibitor AOH1996 is a Small molecule drug developed by City of Hope Medical Center. It is currently in Phase 1 development. Also known as: AOH 1996, AOH-1996, AOH1996, Proliferating Cell Nuclear Antigen Inhibitor AOH1996.

At a glance

Generic namePCNA Inhibitor AOH1996
Also known asAOH 1996, AOH-1996, AOH1996, Proliferating Cell Nuclear Antigen Inhibitor AOH1996, AOH
SponsorCity of Hope Medical Center
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PCNA Inhibitor AOH1996

What is PCNA Inhibitor AOH1996?

PCNA Inhibitor AOH1996 is a Small molecule drug developed by City of Hope Medical Center.

Who makes PCNA Inhibitor AOH1996?

PCNA Inhibitor AOH1996 is developed by City of Hope Medical Center (see full City of Hope Medical Center pipeline at /company/city-of-hope-medical-center).

Is PCNA Inhibitor AOH1996 also known as anything else?

PCNA Inhibitor AOH1996 is also known as AOH 1996, AOH-1996, AOH1996, Proliferating Cell Nuclear Antigen Inhibitor AOH1996, AOH.

What development phase is PCNA Inhibitor AOH1996 in?

PCNA Inhibitor AOH1996 is in Phase 1.

Related